This episode explores the rapid expansion of AI-integrated wearables, focusing on how continuous glucose monitors (CGMs) are transitioning from clinical devices to mainstream wellness tools. We delve into the technological drivers, such as advanced sensors and on-device AI, and the market catalysts, including the 2024 Medicare coverage expansion, that are fueling a 25.53% CAGR in the wearable medtech market. • How are wearables evolving from simple trackers to predictive health monitors? • Why are continuous glucose monitors (CGMs) no longer just for people with diabetes? • What role does Artificial Intelligence (AI) play in real-time health analytics? • Which new over-the-counter devices from companies like Abbott and Dexcom are leading this trend in 2024? • How is the expansion of Medicare coverage accelerating the adoption of wearable medtech? • What does a 25.53% CAGR mean for the future of the wearable medical technology market? • Can these devices truly predict health events before they happen? • What do manufacturers need to know about the regulatory landscape for these new wellness devices? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.